Mikkel Agger

Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B

Yu Zhang, Benjamin Schmid, Nanett Kvist Nikolaisen et al. · Stem Cell Reports · 2017 · 87 citations · Full text

Life Sciences, Genetics, Neuroscience +17

Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation

Helle Bogetofte, Pia Jensen, Justyna Okarmus et al. · Neurobiology of Disease · 2019 · 41 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer’s Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study

Mikkel Agger, Else Rubæk Danielsen, Marcus Schultz Carstensen et al. · Journal of Alzheimer s Disease · 2023 · 34 citations

Medicine, Neurology, Neuroscience +11

Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light

Mikkel Agger, Marcus Schultz Carstensen, Mark Alexander Henney et al. · Journal of Alzheimer s Disease · 2022 · 26 citations · Full text

Life Sciences, Neuroscience, Vision Science +15

<p>The Validity of Intracerebral Hemorrhage Diagnoses in the Danish Patient Registry and the Danish Stroke Registry</p>

Stine Munk Hald, Christine Kring Sloth, Mikkel Agger et al. · Clinical Epidemiology · 2020 · 22 citations · Full text

Medicine, Neurology, Neuroscience +13